Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,705,841
-
Share change
-
-378,717
-
Total reported value
-
$8,035,058
-
Put/Call ratio
-
355%
-
Price per share
-
$2.97
-
Number of holders
-
52
-
Value change
-
-$3,208,497
-
Number of buys
-
17
-
Number of sells
-
38
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q4 2018
As of 31 Dec 2018,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,705,841 shares.
The largest 10 holders included
BlackRock Inc., DEUTSCHE BANK AG\, Vanguard Group Inc, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, CAMPBELL CAPITAL MANAGEMENT INC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Spark Investment Management LLC, and NORTHERN TRUST CORP.
This page lists
52
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.